文献速递主动脉疾病

加速康复外科方案在腹主动脉开放手术中的初步研究

A pilot study of the enhanced recovery after surgery protocol in aortic surgery.
PubMed 文献 · J Vasc Surg · 2020-12-17

这项前瞻性单中心试点研究将开放腹主动脉瘤修复术后加速康复方案(ERAVS)与腔内修复(EVAR)及历史开放手术对照组比较。ERAVS组17例可行性94%,平均出院时间5.1天,EVAR组3.5天,开放对照组8.4天(P<.001)。ERAVS方案较传统开放手术缩短出院时间并改善术后结局,与EVAR组无显著差异。

要点

  • ERAVS方案在开放腹主动脉瘤修复中可行性达94%。
  • ERAVS组平均出院时间5.1天,显著短于开放对照组的8.4天。
  • ERAVS组出院时间与EVAR组3.5天无显著差异。

核心结论

  • 早期经验显示ERAVS方案较标准开放修复可缩短出院时间并改善术后结局,与EVAR相比无显著差异。

研究设计与样本

  • 同期18例EVAR患者为EVAR组,研究前6个月32例标准开放修复患者为历史对照组。
  • 三组按实际治疗比较出院时间、经口进食恢复、下地活动、肠道功能恢复及术后疼痛。

主要发现

  • 平均出院时间:ERAVS组5.1天,EVAR组3.5天,开放对照组8.4天(P<.001)。
  • ERAVS组经口进食恢复和下地活动时间与EVAR组相似,开放对照组显著更长。
  • 肠道功能恢复时间ERAVS组2.6天与开放对照组2.9天相似(P=.6)。
  • 最大疼痛评分均值:ERAVS组3.75(范围1-6),EVAR组2.6(范围0-6),开放对照组4.9(范围1-8;P<.001)。

临床怎么用

  • 对开放AAA修复患者可考虑实施ERAVS加速康复方案以缩短住院时间。
  • ERAVS方案在进食恢复和下地活动方面可达到与EVAR相近的恢复速度。

局限性

  • 单中心小样本试点研究,ERAVS组仅17例。
  • 开放对照组为回顾性历史对照,非随机分组。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: We tested the outcomes with the use of the enhanced recovery after surgery protocol in patients who had undergone open abdominal aortic aneurysm (AAA) repair (enhanced recovery after vascular surgery [ERAVS] protocol). We compared them with those obtained for patients who had undergone endovascular aneurysm repair (EVAR) and for a historical control group of standard open AAA repair in a prospective, single-center pilot study. METHODS: From June to December 2019, all patients who were candidates for open AAA repair at our department were enrolled in the ERAVS protocol (ERAVS group; 17 patients). During the same period, 18 patients had undergone EVAR (EVAR group). The historical control group of standard open AAA repair included 32 patients who had undergone surgery during the 6 months before the study period (standard protocol open repair [OR] group). The three groups were compared on an "on-treatment" basis (prospectively for the ERAVS and EVAR groups and retrospectively for the OR group) in terms of the time to discharge (TTD), interval to the resumption of oral intake, time to ambulation, resumption of bowel function, and postoperative pain. Comparisons were performed using the one-way analysis of variance test, Tukey post hoc test for quantitative data, and χ2 test for qualitative data. RESULTS: The ERAVS protocol was successfully applied for all but one patient (feasibility rate, 94%). The mean TTD was 5.1 days in the ERAVS group, 3.5 days in the EVAR group, and 8.4 days in the OR group [P < .001; F(2,64) = 11.3], with a significant difference between the OR and ERAVS and EVAR groups (P = .1 and P < .001, respectively) but not between the EVAR and ERAVS groups (P = .4). The ERAVS group had intervals to the resumption of oral intake and ambulation similar to those of the EVAR group. In contrast, these were significantly longer for the OR group. The mean time to the resumption of bowel function was similar in the ERAVS and OR groups (2.6 and 2.9 days, respectively; P = .6). In the ERAVS group, the mean value of the maximum referred pain using the numeric rating scale was 3.75 (range, 1-6). The corresponding values for the EVAR and OR groups were 2.6 (range, 0-6) and 4.9 [range, 1-8; F(2,62) = 15.4; P < .001]. The post hoc test showed a significant difference between the OR group and the ERAVS and EVAR group (P = .01 and P < .001, respectively) but not between the ERAVS and EVAR groups (P = .07). CONCLUSIONS: In our early experience, the ERAVS protocol appeared to be effective in reducing the TTD and improving the postoperative outcomes compared with the OR group, without significant differences compared with the EVAR group.

来源:J Vasc Surg,查看原文。版权归原作者所有。

引用

  1. Giacomelli E, Dorigo W, Campolmi M, et al. A pilot study of the enhanced recovery after surgery protocol in aortic surgery. J Vasc Surg. 2020. PMID: 33340704. doi:10.1016/j.jvs.2020.11.042

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。